Premiere Date: Tuesday, May 15, 2018

This activity offers CE credit for:

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Wednesday, May 15, 2019

Begin Activity Now

Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting over 1.3 million Americans and approximately 1% of the global population.1 Many treatment options are available to treat RA, and these agents may

This activity offers CE credit for:

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Monday, May 20, 2019

Ankylosing spondylitis (AS) is a chronic, inflammatory arthritis that affects the axial skeleton. Due to an aging population, declining number of rheumatologists, and limited access to care, care for patients with AS is suboptimal and it is critically important that primary care can optimally recognize and manage these patients. AS is challenging to diagnose and has a 5-10 year delay in diagnosis, the longest diagnostic delay among rheumatic diseases. Studies have shown that patients with shorter disease duration have better response to treatment. A diagnostic delay may cause patients to miss the chance of early appropriate treatment and consequently have poorer prognosis, increased disability, limitation of spinal and hip movements, pain, poor quality of life, and poor functional status.

This CME Outfitters recorded symposium features expert faculty and aims to improve confidence in practitioners that will lead to improved screening, evaluation, and early treatment of individuals with AS.

At the end of this CE activity, participants should be able to:

The following learning objectives pertain only to those requesting CNE or CPE credit:

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Primary car

Premiere Date: Monday, April 30, 2018

This activity offers CE credit for:

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Tuesday, April 30, 2019

Begin Activity Now

Much of the national healthcare debate is centered around gaining insurance coverage for more Americans. But individuals with chronic disease know that their issue is not always about having coverage. It is about gaining access to treatment within their insurance coverage. Forty percent (40%) of prescriptions requiring PA are abandoned or delayed due to current processes. Inefficient PA processes put patients with IBD at risk for poor outcomes from denied access to needed care. Having a plan with proven strategies and resources that meet the needs of the practice can help reduce practice headaches, increase timely patient access to needed medication, and ultimately, improve outcomes and satisfaction in patients with IBD.

The first module of this CME Outfitters 3-part series is designed to provide you with best practice strategies that you can use to improve your success rates for PA and to minimize the impact of prior authorization on staff administrative time, clinical workflow, and patient care. Have questions for our faculty? Use the

Premiere Date: Monday, April 30, 2018

This activity offers CE credit for:

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Tuesday, April 30, 2019

Begin Activity Now

To increase prior authorization (PA) success rates, a detailed protocol for recording and retrieving information about the patient’s disease course within the EHR can minimize barriers and increase the chances that the biologic agent will be deemed medically necessary. It is important to have detailed documentation of IBD diagnosis (including diagnosis codes), colonoscopy results, laboratory results, and detailed disease course information in the EHR progress notes that identify aggressive disease. The non adherence of payer policies to the established, evidence-based AGA Clinical Pathways presents significant barriers to patients in need of appropriate biologic treatment to manage their moderate to severe IBD.

For clinicians, managing the PA process, it underscores the necessity of preparation, documentation, and retrieval of key information from the EHR for the PA submission.

In the second module of this CME Outfitters 3-part series, expert faculty will share best practices for creating processes that ensure importan

Premiere Date: Monday, April 30, 2018

This activity offers CE credit for:

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Tuesday, April 30, 2019

Begin Activity Now

Payers block treatments for more than one-third of patients for their chronic disease. Practices without a sound appeals process can further increase treatment delays for individuals with moderate to severe IBD that need biologic therapy; therefore, it is important to develop an organized appeals process for prior authorizations that are inappropriately declined. A successful appeal is an exercise in organization. Often, denials are a result of clerical error, but other times, a broader appeal is needed to persuade the payer that the physician’s recommendations are warranted. As with the PA process, the appeals process varies by payer, adding to the complexity and the need for a sound process and effective appeal templates.

In the third module of this CME Outfitters 3-part series on prior authorization strategies, expert faculty will focus on creating a structured appeals process for when their prior authorization request is declined. Have questions for our faculty? Use the comment box below the presentation. The faculty will